[Corrections] Correction to Lancet Oncol 2024; 25: 1337–46

Dawson LA, Ringash J, Fairchild A, et al. Palliative radiotherapy versus best supportive care in patients with painful hepatic cancer (CCTG HE1): a multicentre, open-label, randomised, controlled, phase 3 study. Lancet Oncol 2024; 25: 1337–46—In this Article, in the last paragraph of the Results section, the proportion of patients who reported any grade 2 or worse adverse event 1–3 months after randomisation should have been eight (24%) of 33 patients in the radiotherapy plus best supportive care group.